Zhou, L
Liu, X-D
Sun, M
Zhang, X
German, P
Bai, S
Ding, Z
Tannir, N
Wood, C G
Matin, S F
Karam, J A
Tamboli, P
Sircar, K
Rao, P
Rankin, E B
Laird, D A
Hoang, A G
Walker, C L
Giaccia, A J
Jonasch, E
Article History
Received: 23 March 2015
Revised: 5 August 2015
Accepted: 7 August 2015
First Online: 14 September 2015
Competing interests
: Dr Jonasch has received research funding from Pfizer, Novartis, GSK, Onyx and Exelixis. Dr Jonasch is a consultant for Pfizer, GSK, Novartis and Genentech. The other authors declare no conflict of interest.